Literature DB >> 23924008

Toward new treatments for mantle-cell lymphoma?

Emanuele Zucca, Francesco Bertoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23924008     DOI： 10.1056/NEJMe1307596

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma.

Authors:  Afak Rasheed Salman Zaidi; Sadie Dresman; Charlotte Burt; Simon Rule; Lynn McCallum
Journal:  J Cell Commun Signal       Date:  2018-11-21       Impact factor: 5.782

2.  Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.

Authors:  Ryan Incrocci; Levi Barse; Amanda Stone; Sai Vagvala; Michael Montesano; Vijay Subramaniam; Michelle Swanson-Mungerson
Journal:  Virology       Date:  2016-10-25       Impact factor: 3.616

3.  Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models.

Authors:  Chiara Tarantelli; Martin Lange; Eugenio Gaudio; Luciano Cascione; Filippo Spriano; Ivo Kwee; Alberto J Arribas; Andrea Rinaldi; Thibaud Jourdan; Melanie Berthold; Andrea Sturz; Carolyn Sperl; Francesco Margheriti; Lorenzo Scalise; Giuseppe Gritti; Davide Rossi; Anastasios Stathis; Ningshu Liu; Emanuele Zucca; Oliver Politz; Francesco Bertoni
Journal:  Blood Adv       Date:  2020-03-10

Review 4.  Selective inhibitors of nuclear export (SINE)--a novel class of anti-cancer agents.

Authors:  Kaushal Parikh; Shundong Cang; Arunabh Sekhri; Delong Liu
Journal:  J Hematol Oncol       Date:  2014-10-15       Impact factor: 17.388

5.  Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736.

Authors:  Valentina Restelli; Rosaria Chilà; Monica Lupi; Andrea Rinaldi; Ivo Kwee; Francesco Bertoni; Giovanna Damia; Laura Carrassa
Journal:  Oncotarget       Date:  2015-11-10

6.  Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma.

Authors:  Xiaohong Zhao; Michelle Y Wang; Huijuan Jiang; Tint Lwin; Paul M Park; Jing Gao; Mark B Meads; Yuan Ren; Tao Li; Jiao Sun; Naima Ahmed Fahmi; Satishkumar Singh; Lalit Sehgal; Xuefeng Wang; Ariosto S Silva; Eduardo M Sotomayor; Kenneth H Shain; John L Cleveland; Michael Wang; Wei Zhang; Jun Qi; Bijal D Shah; Jianguo Tao
Journal:  Cell Rep       Date:  2021-03-16       Impact factor: 9.423

7.  Ibrutinib for B cell malignancies.

Authors:  Aileen Novero; Pavan M Ravella; Yamei Chen; George Dous; Delong Liu
Journal:  Exp Hematol Oncol       Date:  2014-01-28

8.  Primary follicular lymphoma of colon: A case series and review of literature.

Authors:  Abdul Mohammed; Farnaz Shariati; Neethi Paranji; Nisheet Waghray
Journal:  Clin Case Rep       Date:  2021-07-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.